Detalhe da pesquisa
1.
Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma.
Oncologist
; 27(9): e703-e722, 2022 09 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35671201
2.
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.
Cancer Sci
; 109(11): 3554-3563, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30137686
3.
[CapeOX Therapy as a Salvage Treatment for Advanced Gastric Cancer Refractory to S-1, Cisplatin, Irinotecan, and Taxanes].
Gan To Kagaku Ryoho
; 45(11): 1615-1618, 2018 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-30449849
4.
Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study.
Invest New Drugs
; 35(4): 451-462, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28070720
5.
Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Gastric Cancer
; 20(3): 517-526, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27553665
6.
Case Report: Longitudinal monitoring of clonal evolution by circulating tumor DNA for resistance to anti-EGFR antibody in a case of metastatic colorectal cancer.
Front Oncol
; 13: 1203296, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37434969
7.
Hilar/mediastinal and cutaneous drug-induced sarcoidosis-like reaction associated with immune checkpoint inhibitors in metastatic colorectal cancer: a case report.
Front Immunol
; 14: 1203621, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37492584
8.
Erratum to: Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Gastric Cancer
; 20(3): 527, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27629880
9.
[Four cases of esophageal metastasis from breast cancer].
Nihon Shokakibyo Gakkai Zasshi
; 109(6): 921-8, 2012 Jun.
Artigo
Japonês
| MEDLINE | ID: mdl-22688168
10.
Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.
Asian Pac J Cancer Prev
; 23(2): 695-701, 2022 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35225483
11.
Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms.
Jpn J Clin Oncol
; 41(4): 477-82, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21303789
12.
Analgesic effects of indomethacin spray on drug-induced oral mucositis pain in patients with cancer: A single-arm cross-sectional study.
Spec Care Dentist
; 41(4): 498-504, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33735535
13.
Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab.
Sci Rep
; 10(1): 19815, 2020 11 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33188279
14.
A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.
Cancer Chemother Pharmacol
; 83(1): 161-167, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30406285
15.
Iron/IRP-1-dependent regulation of mRNA expression for transferrin receptor, DMT1 and ferritin during human erythroid differentiation.
Exp Hematol
; 35(6): 879-87, 2007 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-17533042
16.
Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.
Cancer Chemother Pharmacol
; 82(5): 839-845, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30167847
17.
Skin Disorders and Primary Tumor Location as Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated with Cetuximab and Chemotherapy
Asian Pac J Cancer Prev
; 19(8): 2325-2330, 2018 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-30141310
18.
A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer.
Cancer Chemother Pharmacol
; 80(4): 707-713, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28849257
19.
[A case of recurrent biliary cystadenocarcinoma successfully treated with 5FU/CDDP systemic chemotherapy].
Nihon Shokakibyo Gakkai Zasshi
; 103(10): 1163-8, 2006 Oct.
Artigo
Japonês
| MEDLINE | ID: mdl-17023760
20.
Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.
Cancer Chemother Pharmacol
; 78(3): 525-31, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27422301